Product Information

CAS No.	1401028-24-7
Product Name	Oliceridine

Biological Targets

OPRM1

Associated Conditions

Pain

* The information provided here is compiled from public sources and is for reference only.

Studies related to this compound and its mechanism of action

Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays.

Archives of toxicology • Vol. 96, Issue 3 • 2022

PMID: 35072756 DOI: 10.1007/s00204-021-03207-9

Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.

Journal of medicinal chemistry • Vol. 59, Issue 18 • 2016

PMID: 27556704 PMC: PMC5344672 DOI: 10.1021/acs.jmedchem.6b00748

A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain.

Pain • Vol. 157, Issue 1 • 2016

PMID: 26683109 DOI: 10.1097/j.pain.0000000000000363

Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers.

Pain • Vol. 155, Issue 9 • 2014

PMID: 24954166 DOI: 10.1016/j.pain.2014.06.011

Oliceridine

CAS No.	1401028-24-7
MDL No.	N/A
MF	C₂₂H₃₀N₂O₂S
MW	386.60
InChI Key	DMNOVGJWPASQDL-OAQYLSRUSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1401028-24-7
Product Name	Oliceridine

Biological Targets

OPRM1

Associated Conditions

Pain

* The information provided here is compiled from public sources and is for reference only.

Oliceridine

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Oliceridine

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Oliceridine

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays.

Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.

A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain.

Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers.

Similar Products

(R)-2-(9-(Pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)acetonitrile

Oliceridine

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays.

Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.

A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain.

Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers.

Similar Products

(R)-2-(9-(Pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)acetonitrile

Documentation